People lose weight via three primary methods: diet and exercise, weight loss surgery and GLP-1 weight loss drugs. The ...
Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this ...
McDonald's shares underperformed in 2024, likely due to the rise of GLP-1 medications. Learn why MCD stock is a Sell.
Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a ...
For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 receptor agonist ...
GlobalData on MSN15h
Hengrui and Kailera report best-in-class data from Phase II GLP-1/GIP trialData from Hengrui’s Phase II trial for its GLP-1/GIP product demonstrated a statistically significant mean weight loss of ...
Market News Alerts Updates that DarioHealth Corp. (Nasdaq: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The ...
Unfortunately for the company, however, the early glimpse at its fourth-quarter performance doesn’t seem to be going over ...
LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...
CHICAGO — The growing number of US consumers using GLP-1 drugs for weight loss are impacting specific sectors of the consumer ...
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback